Overview
Miconazole is a clinically important imidazole antifungal compound first synthesized in 1969. As a high-purity pharmaceutical active ingredient, it meets stringent pharmacopeia standards (USP/EP) for use in human medicines. The compound demonstrates potent activity against Candida species and dermatophytes through inhibition of lanosterol 14α-demethylase. Pharmaceutical-grade miconazole is manufactured under current Good Manufacturing Practice (cGMP) conditions. Its purity typically exceeds 99%, with strict limits on related substances and residual solvents. The global market for miconazole API is driven by increasing fungal infection rates and expanding applications in both human and veterinary medicine.
Physical and Chemical Properties
Miconazole presents as a white to slightly yellowish crystalline powder with a characteristic weak odor. The compound is chemically stable when stored properly but may degrade upon prolonged exposure to light or moisture. Its logP value of approximately 6 indicates high lipophilicity, influencing formulation development. Spectroscopic characterization includes characteristic IR absorption at 3100 cm-1 (N-H stretch) and 1700 cm-1 (C=O stretch). The UV spectrum shows maximum absorption at 272 nm in methanol. Thermal analysis reveals decomposition above 200°C. These properties are critical for quality control during pharmaceutical manufacturing.
Main Applications
In clinical practice, miconazole is formulated into multiple dosage forms. Topical preparations (2% strength) treat cutaneous mycosis, including athlete's foot and ringworm. Vaginal creams and suppositories (typically 100-1200mg doses) address vulvovaginal candidiasis. Oral gel formulations are effective against oropharyngeal thrush. The compound also finds use in combination therapies and veterinary applications. Emerging research explores its potential anticancer properties through angiogenesis inhibition. Industrial applications include preservation of materials susceptible to fungal degradation, though pharmaceutical uses dominate the high-purity market.
Safety and Storage
As a pharmaceutical active, miconazole requires careful handling to maintain stability and prevent contamination. Long-term storage should occur in refrigerated conditions (2-8°C) within sealed, light-resistant containers. Desiccants are recommended to prevent moisture absorption. Safety protocols mandate the use of nitrile gloves, protective eyewear, and respiratory protection when handling powder forms. The compound may cause skin irritation and allergic reactions in sensitive individuals. Spill management requires neutralization with appropriate absorbents followed by disposal as pharmaceutical waste according to local regulations.
B2B Procurement Guide
Pharmaceutical manufacturers should verify suppliers' cGMP compliance and request full analytical documentation, including HPLC purity profiles and residual solvent reports. Batch-to-batch consistency is critical for formulation stability. Consider suppliers with FDA/EMA-approved facilities for regulated markets. Minimum order quantities typically range from 1-10kg for clinical trial materials, with production-scale orders available in 25-50kg drum quantities. Lead times vary from 4-8 weeks depending on testing requirements. Some suppliers offer custom particle size optimization for specific formulation needs, which may command premium pricing.
Related Manufacturers
- 主营：溴代吡咯腈、芥酸、异山梨醇、异山梨醇二甲醚、四氯苯醌、对氨基苯乙酸、四乙酰核糖、对氨基苯甲酸、2,6-二氟苯胺、蒽醌
- 主营：磺酰胺、氧化铌、除醛剂、硅化镱、基硅油、成核剂、酞菁钴、甘氨酸铬、光学树脂、鼠李糖脂、甲磺酸铋、氧化亚铁、封端硅油、左旋乳酸)、六水氯化钇、己基磺酸盐、恩诺沙星钠、二聚季戊四醇、聚醚硫酸酯钠、恶唑啉交联剂、洗手凝胶增稠剂、生物活性玻璃粉、氰基丙烯酸乙酯、脱硫脱氢催化剂
- 主营：敌草隆、球虫酯、2-己二醇、防黄剂HN-130、靛红酸酐、十一烯酸锌、吲哚原料、4-丁二醇、2-丙二醇、氢化松油醇、羟乙甲纤维素、龙胆紫、二甲基乙烯脲、对叔戊基苯酚、3-二羟基丙酮、乙氧酰胺苯甲酯
- 主营：阻燃剂、核蛋白、胶黏剂、水泥浆、硫酸锆、硫酸锂、软焊剂、硫酸锰、指示剂、聚合物、凝聚剂、脱硫粉、四氢萘、磷酸铵、磷酸铁、灭火剂、碳酸镍、肉桂醛、防冻剂、异丁酮、显色剂、成像剂、新癸酸、椰油胺、叔丁醇
- 主营：化工中间体、有机中间体、香精香料、添加剂、表面活性剂、天然/合成树脂、分析试剂、日化原料、催化剂、高分子材料